New research has indicated that treatment with the targeted therapy drug crizotinib stops the growth of lung tumors that developed due to rearrangements of the ROS1 gene. In an article receiving Online First publication in the iNew England Journal of Medicine/i to coincide with a presentation at the European Society for Medical Oncology meeting, an international research team reports that crizotinib treatment led to significant tumor shrinkage in 36 of 50 study ...
Read More
You have just read an article categorized health
titled ROS1-Positive Lung Cancer may Respond to Crizotinib Treatment.
Written by:
editor -
Saturday, September 27, 2014
There are currently no comments for "ROS1-Positive Lung Cancer may Respond to Crizotinib Treatment"
Post a Comment